Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Estes

Showing results (201-210 of 286) with videos related to

Pageof 29
Sort By:
Journal of Zoo and Wildlife Medicine : Official Publication of the American Association of Zoo Veterinarians|December 30, 2011
Pathologic lesions in chimpanzees (Pan trogylodytes schweinfurthii) from Gombe National Park, Tanzania, 2004-2010Karen A Terio, Michael J Kinsel, Jane Raphael, et al.
The Journal of Clinical Investigation|May 24, 2008
Availability of activated CD4+ T cells dictates the level of viremia in naturally SIV-infected sooty mangabeysNichole R Klatt, Francois Villinger, Pavel Bostik, et al.
Plos Pathogens|March 29, 2023
Chronic immune activation and gut barrier dysfunction is associated with neuroinflammation in ART-suppressed SIV+ rhesus macaquesSarah J Byrnes, Kathleen Busman-Sahay, Thomas A Angelovich, et al.
Clinical and Vaccine Immunology : CVI|September 23, 2016
Balancing Trained Immunity with Persistent Immune Activation and the Risk of Simian Immunodeficiency Virus Infection in Infant Macaques Vaccinated with Attenuated Mycobacterium tuberculosis or Mycobacterium bovis BCG VaccineKara Jensen, Myra Grace Dela Pena-Ponce, Michael Piatak, et al.
Journal of Virology|May 20, 2011
One percent tenofovir applied topically to humanized BLT mice and used according to the CAPRISA 004 experimental design demonstrates partial protection from vaginal HIV infection, validating the BLT model for evaluation of new microbicide candidatesPaul W Denton, Florence Othieno, Francisco Martinez-Torres, et al.
Plos Pathogens|May 5, 2017
Genetically-barcoded SIV facilitates enumeration of rebound variants and estimation of reactivation rates in nonhuman primates following interruption of suppressive antiretroviral therapyChristine M Fennessey, Mykola Pinkevych, Taina T Immonen, et al.
Plos Pathogens|October 31, 2014
CD4 depletion in SIV-infected macaques results in macrophage and microglia infection with rapid turnover of infected cellsLuca Micci, Xavier Alvarez, Robin I Iriele, et al.
Pathogens & Immunity|September 23, 2017
A Randomized Controlled Trial of Lisinopril to Decrease Lymphoid Fibrosis in Antiretroviral-Treated, HIV-infected IndividualsLeslie R Cockerham, Steven A Yukl, Kara Harvill, et al.
Nature Immunology|February 19, 2020
HIV-1-induced cytokines deplete homeostatic innate lymphoid cells and expand TCF7-dependent memory NK cellsYetao Wang, Lawrence Lifshitz, Kyle Gellatly, et al.
The Journal of Infectious Diseases|September 24, 2014
Antifibrotic therapy in simian immunodeficiency virus infection preserves CD4+ T-cell populations and improves immune reconstitution with antiretroviral therapyJacob D Estes, Cavan Reilly, Charles M Trubey, et al.
Pageof 29

Showing results (201-210 of 286) with videos related to

Sort By:
Pageof 29
Journal of Zoo and Wildlife Medicine : Official Publication of the American Association of Zoo Veterinarians|December 30, 2011
Pathologic lesions in chimpanzees (Pan trogylodytes schweinfurthii) from Gombe National Park, Tanzania, 2004-2010Karen A Terio, Michael J Kinsel, Jane Raphael, et al.
The Journal of Clinical Investigation|May 24, 2008
Availability of activated CD4+ T cells dictates the level of viremia in naturally SIV-infected sooty mangabeysNichole R Klatt, Francois Villinger, Pavel Bostik, et al.
Plos Pathogens|March 29, 2023
Chronic immune activation and gut barrier dysfunction is associated with neuroinflammation in ART-suppressed SIV+ rhesus macaquesSarah J Byrnes, Kathleen Busman-Sahay, Thomas A Angelovich, et al.
Clinical and Vaccine Immunology : CVI|September 23, 2016
Balancing Trained Immunity with Persistent Immune Activation and the Risk of Simian Immunodeficiency Virus Infection in Infant Macaques Vaccinated with Attenuated Mycobacterium tuberculosis or Mycobacterium bovis BCG VaccineKara Jensen, Myra Grace Dela Pena-Ponce, Michael Piatak, et al.
Journal of Virology|May 20, 2011
One percent tenofovir applied topically to humanized BLT mice and used according to the CAPRISA 004 experimental design demonstrates partial protection from vaginal HIV infection, validating the BLT model for evaluation of new microbicide candidatesPaul W Denton, Florence Othieno, Francisco Martinez-Torres, et al.
Plos Pathogens|May 5, 2017
Genetically-barcoded SIV facilitates enumeration of rebound variants and estimation of reactivation rates in nonhuman primates following interruption of suppressive antiretroviral therapyChristine M Fennessey, Mykola Pinkevych, Taina T Immonen, et al.
Plos Pathogens|October 31, 2014
CD4 depletion in SIV-infected macaques results in macrophage and microglia infection with rapid turnover of infected cellsLuca Micci, Xavier Alvarez, Robin I Iriele, et al.
Pathogens & Immunity|September 23, 2017
A Randomized Controlled Trial of Lisinopril to Decrease Lymphoid Fibrosis in Antiretroviral-Treated, HIV-infected IndividualsLeslie R Cockerham, Steven A Yukl, Kara Harvill, et al.
Nature Immunology|February 19, 2020
HIV-1-induced cytokines deplete homeostatic innate lymphoid cells and expand TCF7-dependent memory NK cellsYetao Wang, Lawrence Lifshitz, Kyle Gellatly, et al.
The Journal of Infectious Diseases|September 24, 2014
Antifibrotic therapy in simian immunodeficiency virus infection preserves CD4+ T-cell populations and improves immune reconstitution with antiretroviral therapyJacob D Estes, Cavan Reilly, Charles M Trubey, et al.
Pageof 29